CKD patients with hypertension were treated with calcium-channel blockers, β blockers, angiotensin-converting enzyme inhibitors, angiotensin receptor blockers and selective α1 adrenergic receptor blockers, and there was no difference in the distribution of these drug between groups. The gene discussed is ACE; the disease is hypertensive disorder.